Lower Corneal Haze and Aberrations in Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty in Fellow Eyes for Fuchs Endothelial Corneal Dystrophy.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 9 7 2020
medline: 6 7 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

To investigate the long-term corneal changes in patients with Fuchs endothelial corneal dystrophy contributing to superior postoperative visual outcomes after Descemet membrane endothelial keratoplasty (DMEK) compared with Descemet stripping automated endothelial keratoplasty (DSAEK). Using retrospective analysis, we evaluated 9 patients with Fuchs endothelial corneal dystrophy who underwent DSAEK in 1 eye and DMEK in the fellow eye. Patients were genotyped for the triplet repeat expansion in the TCF4 gene and imaged using optical coherence tomography, Scheimpflug imaging, and in vivo confocal microscopy through focusing. Eight of 9 subjects were genotyped, and all were found to harbor the triplet repeat expansion. The average time between endothelial keratoplasty and imaging was 76 ± 22 and 37 ± 9 months after DSAEK and DMEK, respectively. The mean best spectacle-corrected visual acuity (logMAR) was 0.04 ± 0.05 and 0.11 ± 0.03 in the DMEK eyes versus DSAEK eyes (P = 0.02), respectively. Posterior corneal higher order aberrations were less in the DMEK eyes compared with fellow DSAEK eyes (0.25 ± 0.06 and 0.66 ± 0.25, respectively, P ≤ 0.01). Using confocal microscopy through focusing, we found that the persistent anterior stromal haze was correlated between the right and left eyes (R = 0.73, P ≤ 0.05), but total stromal backscattering was higher for the DSAEK eyes (P ≤ 0.05). DSAEK inherently results in higher total stromal backscattering (haze) compared with DMEK because of the addition of stromal tissue. Lower higher order aberrations of the posterior cornea and lower total stromal backscattering (haze) may both contribute to superior visual outcomes after DMEK compared with DSAEK.

Identifiants

pubmed: 32639312
doi: 10.1097/ICO.0000000000002416
pmc: PMC7510625
mid: NIHMS1629802
pii: 00003226-202010000-00004
doi:

Substances chimiques

TCF4 protein, human 0
Transcription Factor 4 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1227-1234

Subventions

Organisme : NEI NIH HHS
ID : P30 EY030413
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY013322
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY022161
Pays : United States

Références

Cornea. 2017 Dec;36(12):1445-1451
pubmed: 28957976
Ophthalmology. 2008 Jul;115(7):1179-86
pubmed: 18061268
Ophthalmology. 2010 May;117(5):878-884.e6
pubmed: 20346512
JAMA Ophthalmol. 2013 Jun;131(6):737-44
pubmed: 23579576
Ophthalmology. 2012 Mar;119(3):528-35
pubmed: 22197439
Ophthalmology. 2019 Jul;126(7):946-957
pubmed: 30776384
JAMA Ophthalmol. 2015 Dec;133(12):1386-91
pubmed: 26401622
Invest Ophthalmol Vis Sci. 2014 Jan 02;55(1):33-42
pubmed: 24255041
Ophthalmology. 2016 Nov;123(11):2276-2284
pubmed: 27659544
Am J Ophthalmol. 2015 Jan;159(1):155-9.e1
pubmed: 25448318
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
Eye (Lond). 2015 Mar;29(3):327-32
pubmed: 25412715
Ophthalmology. 2019 Jan;126(1):19-26
pubmed: 29945801
Eye Contact Lens. 2019 Jan;45(1):1-10
pubmed: 30005051
J Cataract Refract Surg. 2015 Jun;41(6):1182-9
pubmed: 26096520
Ophthalmology. 2014 Dec;121(12):2325-33
pubmed: 25156138
Invest Ophthalmol Vis Sci. 2014 Oct 08;55(11):7073-8
pubmed: 25298419
Curr Eye Res. 1997 Mar;16(3):214-21
pubmed: 9088737
Eur J Ophthalmol. 2019 Jan;29(1):15-22
pubmed: 29661044
Cornea. 2016 Aug;35(8):1073-7
pubmed: 27055217
Ophthalmology. 2013 May;120(5):923-30
pubmed: 23380472
Cornea. 2013 Apr;32(4):e36-43
pubmed: 23051907
Am J Ophthalmol. 2012 Jun;153(6):1082-90.e2
pubmed: 22397955
Cornea. 2015 Aug;34(8):845-52
pubmed: 26075461
Eye Contact Lens. 2018 Jan;44(1):55-59
pubmed: 27541972
Ocul Surf. 2015 Jul;13(3):187-203
pubmed: 25998608
PLoS One. 2012;7(11):e49083
pubmed: 23185296
Cornea. 2011 Dec;30(12):1382-6
pubmed: 21993468
Cornea. 2015 Jul;34(7):786-90
pubmed: 25811725
Exp Eye Res. 2016 Dec;153:56-64
pubmed: 27732879
Cornea. 2017 Nov;36(11):1437-1443
pubmed: 28834814
Eye Contact Lens. 2009 Jul;35(4):196-202
pubmed: 19502987
Cornea. 2020 Jun;39(6):691-696
pubmed: 31939923

Auteurs

William H Waldrop (WH)

Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX; and.

Matthew J Gillings (MJ)

Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX; and.

Danielle M Robertson (DM)

Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX; and.

W Matthew Petroll (WM)

Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX; and.

V Vinod Mootha (VV)

Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, TX; and.
Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH